These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20063195)

  • 81. Rebuttal to: Letter to the Editor by Robert Burton, in response to doi:10.1007/s10549-013-2794-5.
    Nickson C; Mason KE; Kavanagh AM
    Breast Cancer Res Treat; 2014 Jun; 145(2):565-6. PubMed ID: 24789442
    [No Abstract]   [Full Text] [Related]  

  • 82. Letter: Prevalence and duration of undetected breast cancer.
    Smith A; Leck I
    Lancet; 1975 Dec; 2(7945):1142-3. PubMed ID: 53620
    [No Abstract]   [Full Text] [Related]  

  • 83. Screening for breast cancer.
    Gallagher HG; Croll J
    Med J Aust; 1977 Nov; 2(19):651. PubMed ID: 607103
    [No Abstract]   [Full Text] [Related]  

  • 84. Molecular characterization of breast cancer aggressiveness.
    Biglia N; De Bortoli M
    Int J Biol Markers; 2003; 18(1):36-9. PubMed ID: 12699061
    [No Abstract]   [Full Text] [Related]  

  • 85. Selection bias in epidemiological studies of screening participants.
    Heuch I; Kvåle G
    J Chronic Dis; 1986; 39(4):323-5. PubMed ID: 3958119
    [No Abstract]   [Full Text] [Related]  

  • 86. International workshop assesses evidence for breast screening.
    Smigel K
    J Natl Cancer Inst; 1993 Mar; 85(6):436-8. PubMed ID: 8445668
    [No Abstract]   [Full Text] [Related]  

  • 87. Breast cancer risk in women who fulfill high-risk criteria: at what age should surveillance start?
    Brandt A; Lorenzo Bermejo J; Sundquist J; Hemminki K
    Breast Cancer Res Treat; 2010 May; 121(1):133-41. PubMed ID: 19641988
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Screening for breast cancer in women 40-49 years of age].
    Riv Inferm; 1997; 16(3):172-7. PubMed ID: 9460467
    [No Abstract]   [Full Text] [Related]  

  • 89. Screening and prevention of breast cancer in primary care.
    Tice JA; Kerlikowske K
    Prim Care; 2009 Sep; 36(3):533-58. PubMed ID: 19616154
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Are the breast cancer screening recommendations clear or confusing?
    Weiner SN; Komarow M
    Manag Care Interface; 2005 Jan; 18(1):81-4. PubMed ID: 15682635
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Breast cancer screening recommendations: dynamic extrapolation of limited data.
    Mooney C; Merajver S
    Breast Cancer Res Treat; 2010 May; 121(1):143-6. PubMed ID: 20063195
    [No Abstract]   [Full Text] [Related]  

  • 92. Early cancer detection programmes for women at high risk for breast and ovarian cancer: a proposal of practical guidelines.
    Beckmann MW; Schnürch HG; Bodden-Heidrich R; Mosny DS; Crombach G; Nitz U; Achnoula M; Bender HG
    Eur J Cancer Prev; 1996 Dec; 5(6):468-75. PubMed ID: 9061278
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [Screening for breast cancer on basis of individual risk assessment for women ineligible for the national population screening program].
    van Asperen CJ; de Bock GH; van der Horst F; de Koning HJ; Rutgers EJ
    Ned Tijdschr Geneeskd; 2001 Jan; 145(3):120-5. PubMed ID: 11206121
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Role of MRI in screening women at high risk for breast cancer.
    Lehman CD
    J Magn Reson Imaging; 2006 Nov; 24(5):964-70. PubMed ID: 17036340
    [TBL] [Abstract][Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.